SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-24-010557
Filing Date
2024-02-05
Accepted
2024-02-05 15:15:59
Documents
1
Group Members
FORESITE CAPITAL FUND VI, L.P.FORESITE CAPITAL MANAGEMENT V, LLCFORESITE CAPITAL MANAGEMENT VI, LLCFORESITE CAPITAL OPPORTUNITY FUND V, L.P.FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLCJAMES TANANBAUM

Document Format Files

Seq Description Document Type Size
1 SC 13G tm244990d1_sc13gs.htm SC 13G 123344
  Complete submission text file 0001104659-24-010557.txt   125264
Mailing Address 600 MONTGOMERY STREET, SUITE 4500 SAN FRANCISCO CA 94111
Business Address 600 MONTGOMERY STREET, SUITE 4500 SAN FRANCISCO CA 94111 415-877-4887
Foresite Capital Fund V, L.P. (Filed by) CIK: 0001792204 (see all company filings)

IRS No.: 843449937 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618
Business Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618 (949) 419-6203
CG Oncology, Inc. (Subject) CIK: 0001991792 (see all company filings)

IRS No.: 371611499 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94327 | Film No.: 24595430
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)